Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show. The BECOME-TSC study evaluated outcomes of Epidiolex (Jazz ...

Bexicaserin is being developed to treat a group of disorders known as developmental and epileptic encephalopathies (DEEs), including Dravet syndrome ... reduced seizure frequency by more than ...

Epidyolex is the first cannabis-based medicine for epilepsy to be licensed and recommended for use in the NHS. This is very welcome and offers a much needed additional treatment option for people ...

The St. Louis Business Journal's Innovation in Philanthropy Awards program, now in its sixth year, celebrates local ...

Research has also explored the effectiveness of VNS in children with genetic forms of epilepsy, such as Dravet syndrome and tuberous sclerosis complex. The results showed that while VNS did not ...

Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...

Advice for carers for people with epilepsy and a learning disability, including information on the link between epilepsy and ...

Jan. 22, 2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate ...

Jan. 22, 2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate ...

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

UK Medical Eligibility Criteria for Contraceptive Use Category 1: A condition for which there is no restriction for the use of the contraceptive method with the condition or in that circumstance.